Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody‐dependent cellular cytotoxicity of EGFR‐ and HER2‐overexpressing esophageal cancer cell linesKousaku Mimura, Hideki Fujii|International Journal of Cancer|2011Cited by 69